These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32101726)

  • 1. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.
    Ceelen W; Ramsay RG; Narasimhan V; Heriot AG; De Wever O
    Trends Cancer; 2020 Mar; 6(3):236-246. PubMed ID: 32101726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor immune microenvironment in peritoneal carcinomatosis.
    Demuytere J; Ernst S; van Ovost J; Cosyns S; Ceelen W
    Int Rev Cell Mol Biol; 2022; 371():63-95. PubMed ID: 35965001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion.
    Ceelen W; Braet H; van Ramshorst G; Willaert W; Remaut K
    Expert Opin Drug Deliv; 2020 Apr; 17(4):511-522. PubMed ID: 32142389
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of Omental Metastases in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases.
    Bonnefoy I; Mohamed F; Bonnot PE; Benzerdjeb N; Isaac S; Cotte E; Glehen O; Passot G
    Dis Colon Rectum; 2020 Sep; 63(9):1251-1256. PubMed ID: 32618618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
    Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
    Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
    Roy P; Canet-Jourdan C; Annereau M; Zajac O; Gelli M; Broutin S; Mercier L; Paci A; Lemare F; Ducreux M; Elias D; Malka D; Boige V; Goéré D; Jaulin F
    Int J Pharm; 2017 Oct; 531(1):143-152. PubMed ID: 28803938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
    Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
    Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis.
    Peng H; Jiang L; Yuan J; Wu X; Chen N; Liu D; Liang Y; Xie Y; Jia K; Li Y; Feng X; Li J; Zhang X; Shen L; Chen Y
    Clin Transl Med; 2024 Oct; 14(10):e70054. PubMed ID: 39422697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG.
    Taibi A; Lo Dico R; Kaci R; Naneix AL; Mathonnet M; Pocard M
    Surg Oncol; 2020 Jun; 33():158-163. PubMed ID: 32561082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse model.
    Saris J; Bootsma S; Verhoeff J; Tuynman JB; Wildenberg ME; Rijnstra ES; Lenos KJ; Garcia Vallejo JJ; Vermeulen L; Grootjans J
    Front Immunol; 2024; 15():1415457. PubMed ID: 39044825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance.
    Shao M; Gao Y; Xu X; Chan DW; Du J
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
    Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
    Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis.
    Demuytere J; Ceelen W; Van Dorpe J; Hoorens A
    Exp Mol Pathol; 2020 Aug; 115():104442. PubMed ID: 32305340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.
    Hall B; Padussis J; Foster JM
    Surg Clin North Am; 2017 Jun; 97(3):671-682. PubMed ID: 28501254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Klaver CEL; van Huijgevoort NCM; de Buck van Overstraeten A; Wolthuis AM; Tanis PJ; van der Bilt JDW; Sagaert X; D'Hoore A
    Ann Surg Oncol; 2018 Jan; 25(1):212-220. PubMed ID: 29076043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
    Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.